CDK9 inhibition as a potential therapeutic strategy in Ewing sarcoma

被引：0
|
作者：
Matsumura, Yuta
Heinz, Richard E.
Allred, Curtis A.
Siddiqui, Adam
Foulks, Jason M.
Warner, Steven L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5984
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5984
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The potential for molecular therapeutic targets in Ewing's sarcoma
    McAllister N.R.
    Lessnick S.L.
    Current Treatment Options in Oncology, 2005, 6 (6) : 461 - 471
  • [42] Nutlin-3a Is a Potential Therapeutic for Ewing Sarcoma
    Pishas, Kathleen I.
    Al-Ejeh, Fares
    Zinonos, Irene
    Kumar, Raman
    Evdokiou, Andreas
    Brown, Michael P.
    Callen, David F.
    Neilsen, Paul M.
    CLINICAL CANCER RESEARCH, 2011, 17 (03) : 494 - 504
  • [43] CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys
    Yang, Xiaojing
    Luo, Wu
    Li, Li
    Hu, Xiang
    Xu, Mingjiang
    Wang, Yi
    Feng, Jianpeng
    Qian, Jianchang
    Guan, Xinfu
    Zhao, Yunjie
    Liang, Guang
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 416
  • [44] Mechanisms controlling CDK9 activity
    Marshall, Renee M.
    Grana, Xavier
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 2598 - 2613
  • [45] Targeting CDK9 for the Treatment of Glioblastoma
    Ranjan, Alice
    Pang, Ying
    Butler, Madison
    Merchant, Mythili
    Kim, Olga
    Yu, Guangyang
    Su, Yu-Ting
    Gilbert, Mark R.
    Levens, David
    Wu, Jing
    CANCERS, 2021, 13 (12)
  • [46] CDK9 inhibitors in cancer research
    Huang, Zhi
    Wang, Tianqi
    Wang, Cheng
    Fan, Yan
    RSC MEDICINAL CHEMISTRY, 2022, 13 (06): : 688 - 710
  • [47] Inhibition of CDK7-dependent transcriptional addiction is a potential therapeutic target in synovial sarcoma
    Li, Xiaoyang
    Dean, Dylan C.
    Yuan, Jin
    Temple, Thomas H.
    Trent, Jonathan C.
    Andrew, E. Rosenberg
    Shengji, Yu
    Francis, J. Hornicek
    Duan, Zhenfeng
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [48] Identification of a novel isoform of Cdk9
    Shore, SM
    Byers, SA
    Maury, W
    Price, DH
    GENE, 2003, 307 : 175 - 182
  • [49] Inhibition of CDK9 activity compromises global splicing in prostate cancer cells
    Hu, Qiang
    Poulose, Ninu
    Girmay, Samuel
    Heleva, Alma
    Doultsinos, Dimitrios
    Gondane, Aishwarya
    Steele, Rebecca E.
    Liu, Xiaozhuo
    Loda, Massimo
    Liu, Song
    Tang, Dean
    Mills, Ian G.
    Itkonen, Harri M.
    RNA BIOLOGY, 2021, 18 : 722 - 729
  • [50] CDK9 inhibition activates innate immune response in prostate cancer cells
    Yalala, Shivani
    Gondane, Aishwarya
    Poulose, Ninu
    Liang, Jing
    Mills, Ian G.
    Itkonen, Harri M.
    CANCER RESEARCH, 2024, 84 (06)
12345